Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck (SCCHN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing

EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT02823574
What this trial is testing

Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 425
Testing effectiveness (Phase 2)Study completedNCT04541355
What this trial is testing

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Who this might be right for
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more
Hyunseok Kang, MD
Testing effectiveness (Phase 2)Study completedNCT00100789
What this trial is testing

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 67
Early research (Phase 1)Ended earlyNCT02334319
What this trial is testing

Ganetespib Window of Opportunity Study in Head and Neck Cancers

Who this might be right for
Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oral Cavity Squamous Cell Carcinoma+13 more
Emory University 3
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Study completedNCT05057247
What this trial is testing

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Head and Neck Cancer+2 more
Glenn J. Hanna 26
Not applicableStudy completedNCT04050761
What this trial is testing

Nivolumab in Patients With Head and Neck Cancer.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck
Bristol-Myers Squibb 502
Early research (Phase 1)Study completedNCT03565445
What this trial is testing

ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 190
Large-scale testing (Phase 3)Ended earlyNCT03452137
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Hoffmann-La Roche 406
Testing effectiveness (Phase 2)Ended earlyNCT03246685
What this trial is testing

Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
HiberCell, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT00459043
What this trial is testing

Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Dana-Farber Cancer Institute 30
Early research (Phase 1)Ended earlyNCT06974734
What this trial is testing

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Carcinoma, Non Small Cell LungCarcinoma, Pancreatic DuctalMalignant Melanoma+1 more
Pfizer 8
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Testing effectiveness (Phase 2)Ended earlyNCT00591149
What this trial is testing

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Who this might be right for
Head and Neck CancerCarcinoma, Squamous
University of Kansas Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT01312350
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Who this might be right for
Hypopharyngeal Cancer
Samsung Medical Center 40
Large-scale testing (Phase 3)Ended earlyNCT05386550
What this trial is testing

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 166
Testing effectiveness (Phase 2)Ended earlyNCT00216138
What this trial is testing

Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck

Who this might be right for
Head and Neck Cancer
Hoosier Cancer Research Network 19
Early research (Phase 1)Study completedNCT01783587
What this trial is testing

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dana-Farber Cancer Institute 29
Testing effectiveness (Phase 2)UnknownNCT02753140
What this trial is testing

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Next Page
16